MetLife EVP Granted 2,655-Share Stock Award

O'Neill Adrienne Karen reported acquisition or exercise transactions in this Form 4 filing.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

O'Neill Adrienne Karen reported acquisition or exercise transactions in this Form 4 filing.

MetLife Inc executive Adrienne Karen O'Neill, EVP & Chief Accounting Officer, received an equity grant of 2,655 shares of common stock on February 24, 2026. The shares were awarded at $0.00 per share as a restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan, increasing her directly owned holdings to 14,557 shares.

Insider Trade Summary

Grant/Award: 2,655 shares

Grant/Award 1 txn

Insider O'Neill Adrienne Karen

Role EVP & Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,655	$0.00	$0.00

Holdings After Transaction: Common Stock — 14,557 shares (Direct)

Footnotes (1)

F1. Restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MET executive Adrienne O'Neill report on this Form 4?

Adrienne Karen O'Neill reported receiving an equity award of 2,655 shares of MetLife common stock. The grant was made at $0.00 per share as part of her compensation and classified as a restricted stock unit award under MetLife’s 2025 Stock and Incentive Compensation Plan.

Was the MetLife (MET) Form 4 transaction a purchase or a grant?

The MetLife Form 4 transaction was a grant, not an open-market purchase. Code “A” identifies it as a grant, award, or other acquisition, reflecting a restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan rather than a cash-funded share purchase.

How many MetLife (MET) shares does Adrienne O'Neill own after this Form 4 grant?

After the reported grant, Adrienne Karen O'Neill directly owns 14,557 shares of MetLife common stock. This total reflects the addition of 2,655 shares from the restricted stock unit award disclosed, with ownership reported as direct in the Form 4 filing’s ownership details.

What does the footnote on the MetLife (MET) Form 4 restricted stock unit award explain?

The footnote explains that the 2,655-share transaction is a restricted stock unit award granted under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan. This clarifies the award arises from a company compensation program rather than market trading or a discretionary stock purchase.

What is transaction code "A" in the MetLife (MET) Form 4 for Adrienne O'Neill?

Transaction code “A” indicates a grant, award, or other acquisition of securities. In this MetLife Form 4, it refers to the 2,655-share restricted stock unit award given to Adrienne Karen O'Neill as part of the MetLife, Inc. 2025 Stock and Incentive Compensation Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/26/2026 - 04:36 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Neill Adrienne Karen

(Last)

(First)

(Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK

10166

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP & Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/24/2026		A		2,655	A	⁽¹⁾	14,557	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR